433 related articles for article (PubMed ID: 31885776)
21. Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2.
Wang A J; Tang Y; Zhang J; Wang B J; Xiao M; Lu G; Li J; Liu Q; Guo Y; Gu J
Redox Biol; 2022 Jun; 52():102310. PubMed ID: 35452917
[TBL] [Abstract][Full Text] [Related]
22. Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ.
He H; Luo Y; Qiao Y; Zhang Z; Yin D; Yao J; You J; He M
Food Funct; 2018 Aug; 9(8):4404-4418. PubMed ID: 30063064
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-22 inhibition prevents doxorubicin-induced cardiotoxicity via upregulating SIRT1.
Xu C; Liu CH; Zhang DL
Biochem Biophys Res Commun; 2020 Jan; 521(2):485-491. PubMed ID: 31677784
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2.
Zhao L; Qi Y; Xu L; Tao X; Han X; Yin L; Peng J
Redox Biol; 2018 May; 15():284-296. PubMed ID: 29304479
[TBL] [Abstract][Full Text] [Related]
25. Protective effect of berberine on doxorubicin‑induced acute hepatorenal toxicity in rats.
Chen X; Zhang Y; Zhu Z; Liu H; Guo H; Xiong C; Xie K; Zhang X; Su S
Mol Med Rep; 2016 May; 13(5):3953-60. PubMed ID: 27035423
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of berberine on acute cardiomyopathy associated with doxorubicin treatment.
Xiong C; Wu YZ; Zhang Y; Wu ZX; Chen XY; Jiang P; Guo HC; Xie KR; Wang KX; Su SW
Oncol Lett; 2018 Apr; 15(4):5721-5729. PubMed ID: 29552206
[TBL] [Abstract][Full Text] [Related]
27. Columbianadin attenuates doxorubicin-induced cardiac injury, oxidative stress, and apoptosis via Sirt1/FOXO1 signaling pathway.
Peng B; Rao L; Yang J; Ku X; Kong B; Shuai W; Huang H
Acta Cir Bras; 2023; 38():e382223. PubMed ID: 37377248
[TBL] [Abstract][Full Text] [Related]
28. Modulatory effect of metformin on cardiotoxicity induced by doxorubicin via the MAPK and AMPK pathways.
Chen J; Zhang S; Pan G; Lin L; Liu D; Liu Z; Mei S; Zhang L; Hu Z; Chen J; Luo H; Wang Y; Xin Y; You Z
Life Sci; 2020 May; 249():117498. PubMed ID: 32142765
[TBL] [Abstract][Full Text] [Related]
29. Bcl-xL is required for the protective effects of low-dose berberine against doxorubicin-induced cardiotoxicity through blocking apoptosis and activating mitophagy-mediated ROS elimination.
Chen B; Zhang JP
Phytomedicine; 2022 Jul; 101():154130. PubMed ID: 35526324
[TBL] [Abstract][Full Text] [Related]
30. Cariporide Attenuates Doxorubicin-Induced Cardiotoxicity in Rats by Inhibiting Oxidative Stress, Inflammation and Apoptosis Partly Through Regulation of Akt/GSK-3β and Sirt1 Signaling Pathway.
Liao W; Rao Z; Wu L; Chen Y; Li C
Front Pharmacol; 2022; 13():850053. PubMed ID: 35747748
[No Abstract] [Full Text] [Related]
31. Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1/LKB1/AMPK pathway.
Wang S; Wang Y; Zhang Z; Liu Q; Gu J
Cell Death Dis; 2017 Aug; 8(8):e3018. PubMed ID: 28837153
[TBL] [Abstract][Full Text] [Related]
32. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53.
Zhang C; Feng Y; Qu S; Wei X; Zhu H; Luo Q; Liu M; Chen G; Xiao X
Cardiovasc Res; 2011 Jun; 90(3):538-45. PubMed ID: 21278141
[TBL] [Abstract][Full Text] [Related]
34. Xinmailong Attenuates Doxorubicin-Induced Lysosomal Dysfunction and Oxidative Stress in H9c2 Cells via HO-1.
Jiang Y; Liu Y; Xiao W; Zhang D; Liu X; Xiao H; You S; Yuan L
Oxid Med Cell Longev; 2021; 2021():5896931. PubMed ID: 33854694
[TBL] [Abstract][Full Text] [Related]
35. Alleviation of the acute doxorubicin-induced cardiotoxicity by Lycium barbarum polysaccharides through the suppression of oxidative stress.
Xin YF; Wan LL; Peng JL; Guo C
Food Chem Toxicol; 2011 Jan; 49(1):259-64. PubMed ID: 21056614
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway.
Lu G; Liu Q; Gao T; Li J; Zhang J; Chen O; Cao C; Mao M; Xiao M; Zhang X; Wang J; Guo Y; Tang Y; Gu J
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235670
[TBL] [Abstract][Full Text] [Related]
37. CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1.
Yuan YP; Ma ZG; Zhang X; Xu SC; Zeng XF; Yang Z; Deng W; Tang QZ
J Mol Cell Cardiol; 2018 Jan; 114():38-47. PubMed ID: 29061338
[TBL] [Abstract][Full Text] [Related]
38. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
Guo R; Lin J; Xu W; Shen N; Mo L; Zhang C; Feng J
Int J Mol Med; 2013 Mar; 31(3):644-50. PubMed ID: 23338126
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity.
Cui L; Guo J; Zhang Q; Yin J; Li J; Zhou W; Zhang T; Yuan H; Zhao J; Zhang L; Carmichael PL; Peng S
Toxicol Lett; 2017 Jun; 275():28-38. PubMed ID: 28456571
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway.
Du J; Hang P; Pan Y; Feng B; Zheng Y; Chen T; Zhao L; Du Z
Toxicol Appl Pharmacol; 2019 Apr; 369():73-81. PubMed ID: 30831132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
